Pharmacoepidemiology
نویسندگان
چکیده
منابع مشابه
Pharmacoepidemiology, Adverse and Beneficial Effects
Pharmacoepidemiology has been defined as “the study of the distribution and determinants of drugrelated events in populations and the application of this study to efficacious drug treatment” [26]. Similar definitions have been given by several authors [37, 53]. The term “drug” in the definition is generally understood to include biologics, such as vaccines, and the populations are understood to...
متن کاملRelevance of pharmacoepidemiology to Nepal.
Drug-related problems such as overuse of injectable drug products and antimicrobials, increased cost of drug therapy, polypharmacy, and adverse drug reactions (ADRs) are prevalent in the healthcare settings of Nepal. To date, no new drug development processes or clinical trials have been conducted in Nepal, despite the fact that studies of real life situations are an essential tool for monitori...
متن کاملAdvances in Pharmacoepidemiology & Drug Safety
This article was originally published in a journal by OMICS Publishing Group, and the attached copy is provided by OMICS Publishing Group for the author’s benefit and for the benefit of the author’s institution, for commercial/research/educational use including without limitation use in instruction at your institution, sending it to specific colleagues that you know, and providing a copy to you...
متن کاملTowards New Tools for Pharmacoepidemiology
Monitoring the outcomes for patient health of marketed drugs is an important tool to raise alerts and analyze adverse drug reactions. It also has multiple quantitative purposes related to that. It can establish the pharmacogenomics and relevant environmental factors to stratify the population into those who will be benefited and those who are at risk, which is important in repurposing and prici...
متن کاملServices and prevention: pharmacoepidemiology of antidepressant use.
Between 1988 and 1994, data from 3 large sites revealed a 3-5 fold increase in the prevalence of antidepressant (ATD) treatment for U.S. youths aged 2-19 years. In 1994, the ATD prevalence for youths of this age ranged from 13 per 1000 (in the HMO) to 18 per 1000 (in 2 state Medicaid systems). Males predominated in the 10-14-year-olds treated with ATDs, whereas females predominated among 15-19-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Epidemiology & Community Health
سال: 1996
ISSN: 0143-005X
DOI: 10.1136/jech.50.2.230